AzTrials
AzTrials

Colon CancerABPNCT00817934

Safe, Effective, and More Tolerable 16 Tablets Colon Prep

An observational study of Colon Cancer, run by Long Neck Medical Enterprises at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is determine if the AB Prep (a 16 tablets colon cleansing prep), is an effective, and safe colon cleansing prep in preparation for colonoscopy, and severe constipation. Read more about this study

Who is it for?
Ages 12 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Colon Cancer
What is being tested?
AB PREP
Type of treatment
Pill or oral medicine
How many people
400 participants
Where
1 siteUnited States
Study dates
Jan 2009to Jan 2010
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Any patient between the age of 12 and 75, who is eligible for colonoscopy.

Who may be able to join

  • Any eligible patient for colonoscopy

Who cannot join

  • Patients with renal failure

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Cedar Tree Surgical Center

    Millsboro, Delaware, 19966

Other trials in United States

About this study

Official title: Phase III of the AB Prep Safety and Efficacy in Colon Cleansing

The purpose of this study is determine if the AB Prep (a 16 tablets colon cleansing prep), is an effective, and safe colon cleansing prep in preparation for colonoscopy, and severe constipation.

Read the detailed description

The available colon cleansing preps have issues with patient's tolerance( Abdominal pain, nausea, vomiting), and as recently noted by the FDA safety issues such a change in EKG, blood electrolytes requiring 72 hours to correct, and most recently PO4 nephropathy.

The AB Prep is a 16 tablets prep that has excellent patient's tolerance efficacy, with no change in blood electrolytes or EKG. ( PhaseI (20 patients) and Phase II (200 patients)

The protocol that was used is as follows:

(IND application # 75,704)

Protocol design for testing the safety and efficacy of the AB Prep:

The AB Prep is a combination of 2 Reglan tablets (10mg each), 6 Dulcolax tablets, and 8 K-Phos Neutral tablets. The combination is given in two steps, four hours apart; the day before the colonoscopy.

As before, the objective of this clinical trial is to examine the AB Prep first and foremost for safety, and second for efficacy of colon cleansing.

The proposed trial is for One-Arm Study of subjects undergoing elective and therapeutic colonoscopy.

Phase III: 400 patients, The selection will be random, the age probably ranging from 12 to 75 years old.

The patients will have a Pre, and post procedural EKG, comprehensive (Sodium, Potassium, Creatinine, BUN, Calcium, Magnesium, Phosphate, Glucose), and vital signs.

The patients with severe constipation (One bowel movement per week or more) will not be included in the study. (In our experience, those people required two days prep to achieve colon cleansing).

The SRSS statistical program will be used for data collection and analysis:

The end point of the study is colon cleansing, adequate enough to perform colonoscopy. The colon cleansing will be graded as follow:

  1. Poor colon prep, unable to proceed with colonoscopy.
  2. Able to do colonoscopy with, the colon cleansing labeled as:

A- Excellent, Totally cleansed B- Good, adequately cleansed, with need for irrigation.

In addition to efficacy, we would like to check for patient's satisfaction and compliance, (Most common complaints that the patients tend to voice with the present approved colon preps).

Patient's satisfaction data will be collected before the procedure and will be graded as follow:

  1. Totally satisfied with the Prep, without any complaints
  2. Satisfied, with the following complaints (Nausea, vomiting, abdominal pain/cramping)
  3. Unsatisfied with the Prep (Reasons!!!)

Patient's compliance will be graded as follow:

  1. Compliant
  2. Non compliant(Reasons).

The prep instruction will be as follows REPARATION FOR COLONOSCOPY

FIVE DAYS before your procedure:

  1. If you take COUMADIN or PLAVIX, we recommend that you stop these medications. You must contact your primary care physician or cardiologist for specific instructions. You may restart these medications again after the procedure unless otherwise instructed.
  2. If you have DIABETES and take medication to control your blood sugar, contact your primary care physician or diabetes doctor for instructions about how to take your diabetes medication while preparing for this procedure.
  3. Stop taking iron or multivitamins that contain iron.
  4. Avoid the use of aspirin and aspirin-like medications such as ibuprofen, Advil and Aleve. These medicines may increase your risk of bleeding after polyp removal.
  5. Start a low-roughage diet and do not eat corn or raw vegetables. You may re-start your usual diet after the procedure.

TWO DAYS before the procedure:

  1. Take 2 tablets of Dulcolax at 8:00 PM.

ONE DAY before the procedure:

  1. Begin a clear liquid diet at breakfast and continue this diet until 4 hours before your procedure. A clear liquid diet includes: water, tea, black coffee, clear broth, apple juice, white grape juice, Gatorade, soda, Jell-O. Do not eat or drink anything red, including red Jell-O. Do not drink milk. Do not use sugar-free drinks. All patients, including those with DIABETES, should be sure they get enough sugar during this time.
  2. At 8:00 AM, take One Reglan(10mg) tablet, 2 Dulcolax tablets, and 4 tablets of K-PHOS NEUTRAL. Drink three glasses of water/juice SLOWLY over 1 hour. The laxative effect begins in about 2 hours. BE SURE TO DRINK AT LEAST 3 GLASSES OF WATER OR JUICE AFTER TAKING EACH DOSE OF THE prep.( Each Glass =350cc)
  3. At 12:00 Noon, Take 2 Dulcolax tablets and 4 tablets of K-PHOS NEUTRAL, along with 3 glasses of water/Juice.(Each glass =350cc).

ON THE DAY of your procedure:

  1. Take all of your usual medicines and 1 tablet of Reglan (10mg). Do Not Take Coumadin, Plavix, or Aspirin. If you take INSULIN, take 1/2 your usual dose.
  2. If you have a medical condition requiring antibiotics before or after procedures, we will determine whether they are needed for your colonoscopy.
  3. STOP CLEAR LIQUIDS 4 HOURS BEFORE YOUR PROCEDURE (except for small amount of water with medications). DO NOT EAT OR DRINK ANYTHING UNTIL AFTER YOUR PROCEDURE.
  4. Wear loose-fitting, comfortable clothes.
  5. Read the consent form. You will be asked to sign the form before your procedure.

Please bring these things WITH YOU to your procedure:

  1. A list of all of your medications, including the doses
  2. Your identification or insurance card
  3. The name and phone number of your escort.

AFTER your procedure:

  1. You will be monitored in the Endoscopy Unit recovery area for 20-30 minutes.
  2. You may have some abdominal bloating after the procedure. It should resolve within an hour.
  3. You may eat your normal diet after the procedure.
  4. You may return to work the day after the procedure.

HELPFUL HINTS FOR PATIENTS UNDERGOING COLONOSCOPY

1.Use moist wipes (baby wipes) instead of toilet paper.

Conditions
Colon Cancer
Being tested
AB PREP
Keywords
Efficacy, patient's tolerance, patient's safety
Medical subject headings
Colonic Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AB PREPDrug

    Also called Reglan, K-Phos neutral, and Dulcolax

    Potassium phosphate and Sodium Phosphate,(in the form of K-phos neutral 8 tablets.(Bisacodyl)6tablets. The third medication is (Metoclopramide).

Study groups in NCT00817934
Study groupRoleWhat they receive
PREVENTION AND TREATMENTPATIENTS 50 YEARS AND OLDER REQUIRE SCREENING COLONOSCOPY. PATIENTS WITH FAMILY HISTORY OF COLON CANCER WILL REQUIRE IT BEFORE THE AGE OF 50.
Receives: Drug: AB PREP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. TOTAL COLON CLEANSING, TO BE ABLE TO PERFORM COLONOSCOPY

    Measured: IMMEDIATE, DURING THE COLONOSCOPY

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2009 (estimated)
  2. Study startJan 2009
  3. Primary completionJan 2010 (estimated)
  4. Study completionJan 2010 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00817934
Sponsor's protocol ID
ABBPREP1
Other IDs
AB1
Acronym
ABP
Status last verified
Jan 2009
First submitted
5 Jan 2009
Last updated
7 Jan 2009
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Colon Cancer, run by Long Neck Medical Enterprises at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Jan 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

TOTAL COLON CLEANSING, TO BE ABLE TO PERFORM COLONOSCOPY (time frame: IMMEDIATE, DURING THE COLONOSCOPY). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2009.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in